Key facts
- This page summarizes Kimberley A. Elting's Form 4 filing for Orthofix Medical Inc. (OFIX).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 09 Jan 2024, 16:44.
Kimberley A. Elting - 05 Jan 2024 Form 4 Insider Report for Orthofix Medical Inc. (OFIX)
- Reporting relationship
- President, Global Orthopedics
- Issuer ticker
- OFIX
- Reported as of
- 05 Jan 2024
- Net transaction value
- -$316,237
- SEC form
- 4
- Accepted by SEC
- 09 Jan 2024, 16:44:04 UTC
- Prior SEC filing
- 05 Jan 2024
- Next SEC filing
- 05 Feb 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kimberley A. Elting
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Kimberley A. Elting filed Form 4 for Orthofix Medical Inc. (OFIX) on 09 Jan 2024.
Change
- Previous filing in this sequence was filed on 05 Jan 2024.
- Current net transaction value: -$316,237.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
OFIX
transaction
Common Stock
Tax liability
- Transaction value
- $66,239
- Shares
- -5,228
- Change %
- -2.3%
- Price
- $12.67
- Shares after
- 220,187
- Date
- 05 Jan 2024
- Ownership
- Direct
- Footnotes
- F1
OFIX
transaction
Common Stock
Award
- Transaction value
- $249,998
- Shares
- -18,811
- Change %
- -7.3%
- Price
- $13.29
- Shares after
- 238,998
- Date
- 08 Jan 2024
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
OFIX
transaction
Derivative
Employee Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +43,867
- Change %
- Price
- $0.000000
- Shares after
- 43,867
- Date
- 08 Jan 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 43,867
- Exercise price
- $13.29
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Includes 157,609 previously reported unvested restricted stock units.
Footnote F2
The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered hereby on each of the first, second and third anniversaries of the Grant Date.
Footnote F3
The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first anniversary of the Grant Date and one-twelfth (1/12th) of the shares covered thereby on each of the 15-month, 18-month, 21-month, 24-month, 27-month, 30-month, 33-month and 36-month anniversaries of the Grant Date.